Charter's Q3 10-Q Details $2.4B Loss, $6.3B Franchise Writedown and 3.93x Leverage
CHTR sits 16% above its 52-week low of $101.11.
Summary
Charter's Q3 10-Q shows a $2.4 billion net loss driven by a $6.3 billion non-cash franchise impairment, with free cash flow down to $674 million and leverage at 3.93x Adjusted EBITDA.
Key Events · Earnings and Guidance · CHTR
-
Q3 Loss on $6.3B Franchise Writedown
Net loss attributable to Charter shareholders was $2,397 million, or $20.50 per basic share, after a $6,326 million non-cash franchise impairment, partly offset by a $1,391 million gain on debt extinguishment.
-
Free Cash Flow Falls Sharply
Free cash flow was $674 million in Q3 and $3,015 million for nine months, versus $1,621 million and $4,231 million a year earlier, as capital spending rose to $8,753 million year-to-date.
-
Leverage at 3.93x After Cox Deal
Net debt to last-twelve-months Adjusted EBITDA, excluding transition expenses, was 3.93x at September 30, 2026, against a plan to reach 3.5x within three years of closing; total debt principal was $108,574 million.
-
Impairment Sensitive to Discount Rates
A 50-basis-point increase in the discount rate would push the unimpaired franchise unit to its carrying amount and add roughly $1.9 billion to the impairment charge.
Analysis · CHTR · Technology
The $6.3 billion non-cash franchise impairment grabs the headline, but leverage is the number that matters for the thesis: 3.93x net debt to Adjusted EBITDA against a stated 3.5x target within three years. Free cash flow of $674 million in Q3 versus $1,621 million a year earlier shows how much less cash the business throws off after absorbing Cox, and the filing itself flags that a 50-basis-point rise in discount rates would add roughly $1.9 billion to the writedown. The impairment is an accounting charge, not cash leaving the company, but it confirms management marked down long-term customer and revenue growth expectations.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CHTR was trading at $116.91 on NASDAQ in the Technology sector, with a market capitalization of approximately $22.2B. The 52-week trading range was $101.11 to $254.11. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.